Characterization of intestinal microbiota in patients with psoriasis combined with metabolic syndrome
- 20 August 2025
- journal article
- research article
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 480 (12) , 6181-6196
Abstract
The co-morbidity of psoriasis (PsO) and metabolic syndrome (MetS) is prevalent. While the mechanisms causing PsO in MetS remain unknown, it is understood that gut microbiota plays a critical role in maintaining immune and metabolic balance. However, the specific mechanisms and whether biomarkers are involved in the pathophysiological process of PSO in MetS patients have yet to be elucidated. This study involved 29 patients with PSO and MetS (PM) and 29 with MetS (M). It analyzed their clinical parameters, microbial composition, function, diagnostic, and predictive performance. The results unveiled significant differences between the two groups concerning microbial diversity and community composition. Most of the differential microbiota in the PM group exhibited a negative correlation with high-density lipoprotein (HDL) and a positive correlation with serum uric acid (SUA). In contrast, the opposite was observed in the M group. Sixteen MetaCyc pathways showed significance in the PM group, encompassing peptidoglycan biosynthesis II (staphylococci), the super pathway of L-arginine and L-ornithine degradation, teichoic acid (poly-glycerol) biosynthesis, and palmitic biosynthesis II (bacteria and plants). Six KEGG pathways were enriched in the M group, such as flavone, flavonol biosynthesis, and carotenoid biosynthesis. Most importantly, we determined that eight biomarkers, represented by Akkermansia, demonstrated robust diagnostic predictive power. This study elucidates the potential mechanism through which metabolic disorders impact the onset and progression of psoriasis via intestinal microbiota. Furthermore, it offers novel strategies for preventing, diagnosing, and treating PsO in MetS.Keywords
Funding Information
- Tianjin Municipal Health Committee (2023129)
- Scientific Research Program of Tianjin Key Area of Traditional Chinese Medicine (2022003)
This publication has 97 references indexed in Scilit:
- Pro‐inflammatory cytokine IL‐6 regulates LMO4 expression in psoriatic keratinocytes via AKT/STAT3 pathwayImmunity, Inflammation and Disease, 2023
- Microbial network signatures of early colonizers in infants with eczemaiMeta, 2023
- Carotenoids and Their Health Benefits as Derived via Their Interactions with Gut MicrobiotaAdvances in Nutrition, 2022
- Potential mechanism of oral baicalin treating psoriasis via suppressing Wnt signaling pathway and inhibiting Th17/IL‐17 axis by activating PPARγPhytotherapy Research, 2022
- Quercetin Impedes Th17 Cell Differentiation to Mitigate Arthritis Involving PPARγ‐Driven Transactivation of SOCS3 and Redistribution Corepressor SMRT from PPARγ to STAT3Molecular Nutrition & Food Research, 2022
- Genetic tools for the redirection of the central carbon flow towards the production of lactate in the human gut bacterium Phocaeicola (Bacteroides) vulgatusApplied Microbiology and Biotechnology, 2022
- Inulin supplementation ameliorates hyperuricemia and modulates gut microbiota in Uox-knockout miceEuropean Journal of Nutrition, 2020
- The Global Epidemic of the Metabolic SyndromeCurrent Hypertension Reports, 2018
- The Microbiome and Risk for Obesity and DiabetesJAMA, 2017
- Free fatty acids sensitize dendritic cells to amplify TH1/TH17‐immune responsesEuropean Journal of Immunology, 2016